Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice
Personalisierte Antiemese reduziert CINV
Nurses urge “zero tolerance” for CINV
Chemotherapy-Induced Nausea/Vomiting (CINV)
Multicenter phase IV study of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy
Reducing CINV with ginger.
Granisetron patch launched for CINV in the US.
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population
New management strategies for CINV.